Cargando…
Disutility of injectable therapies in obesity and type 2 diabetes mellitus: general population preferences in the UK, Canada, and China
INTRODUCTION: Once-daily and once-weekly injectable glucagon-like peptide-1 receptor agonist therapies (GLP-1 RAs) are established in obesity and type 2 diabetes mellitus (T2DM). In T2DM, both once-daily and once-weekly insulin are expected to be available. This study elicited utilities associated w...
Autores principales: | McEwan, Phil, Baker-Knight, James, Ásbjörnsdóttir, Björg, Yi, Yunni, Fox, Aimee, Wyn, Robin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080344/ https://www.ncbi.nlm.nih.gov/pubmed/35526173 http://dx.doi.org/10.1007/s10198-022-01470-w |
Ejemplares similares
-
Disutility associated with cancer screening programs: A systematic review
por: Li, Lin, et al.
Publicado: (2019) -
Disutility Study for Adult Patients with Moderate to Severe Crohn’s Disease
por: Worbes-Cerezo, Melany, et al.
Publicado: (2019) -
Quantifying the impact of taking medicines for primary prevention: a time-trade off study to elicit direct treatment disutility in the UK
por: Thompson, Alexander, et al.
Publicado: (2023) -
It is not always about gains: utilities and disutilities associated with treatment features in patients with moderate-to-severe psoriasis
por: Umar, Nasir, et al.
Publicado: (2012) -
Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model exploration
por: Omidvari, Amir-Houshang, et al.
Publicado: (2021)